Impact of Medical Emergency Team and EMS in Tampere University Hospital
NCT ID: NCT01214460
Last Updated: 2019-09-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
10000 participants
OBSERVATIONAL
2010-01-31
2019-09-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Epidemiology and Cost-effectiveness of Out-Of-Hospital Cardiac Arrest in Finland
NCT01295424
Out-of Hospital Resuscitation Study
NCT00196248
Survival Study After Out-of-hospital Cardiac Arrest
NCT02184468
The Use of a Point-of-care Thoracic Ultrasound Protocol for Hospital Medical Emergency Teams
NCT03214809
Influences of DNAR Order Prohibition on Hospital Discharged Ratios and Neurological Outcomes at Discharge
NCT02585050
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
All MET calls
We make an Utstein type analyze to all MET calls
No interventions assigned to this group
All EMS calls
We make an Utstein type analyze to all EMS calls during June 2015
No interventions assigned to this group
All patient in the emergency department
We make an Utstein type analyze to all Emergency visits during June 2015
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jari Kalliomäki, MD
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Sanna Hoppu, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Joonas Tirkkonen, MD
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Timo Kontula, MD
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Eetu Loisa
Role: PRINCIPAL_INVESTIGATOR
Tampere University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere University Hospital
Tampere, Pirkanmaa, Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R10111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.